tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Technical Analysis

422 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Neurogene’s (NGNE) Moving Averages Convergence Divergence (MACD) indicator is -1.00, suggesting Neurogene is a Sell.
Neurogene’s (NGNE) 20-Day exponential moving average is 33.66, while Neurogene’s (NGNE) share price is $34.01, making it a Sell.
Neurogene’s (NGNE) 50-Day exponential moving average is 34.63, while Neurogene’s (NGNE) share price is $34.01, making it a Sell.

Neurogene (NGNE) Pivot Points

May 21, 2024, 12:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
30.53
31.77
32.74
33.98
34.95
36.19
37.16
Fibonacci
31.77
32.61
33.13
33.98
34.82
35.34
36.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurogene (NGNE) Moving Averages

May 21, 2024, 12:34 AM
Period
Simple
Exponential
MA5
32.56Buy
33.07Buy
MA10
32.82Buy
33.04Buy
MA20
32.68Buy
33.66Sell
MA50
37.68Sell
34.63Sell
MA100
33.46Sell
32.10Buy
MA200
23.88Buy
25.70Buy
Neurogene’s (NGNE) 10-Day exponential moving average is 33.04, while Neurogene’s (NGNE) share price is $34.01, making it a Buy.
Neurogene’s (NGNE) 100-Day exponential moving average is 32.10, while Neurogene’s (NGNE) share price is $34.01, making it a Buy.
Neurogene’s (NGNE) stock price is $34.01 and Neurogene’s (NGNE) 50-day simple moving average is 37.68, creating a Sell signal.
Neurogene’s (NGNE) stock price is $34.01 and Neurogene’s (NGNE) 100-day simple moving average is 33.46, creating a Sell signal.
Neurogene’s (NGNE) stock price is $34.01 and Neurogene’s (NGNE) 200-day simple moving average is 23.88, creating a Buy signal.

Neurogene (NGNE) Technical Indicators

May 21, 2024, 12:34 AM
Name
Value
Implied Action
RSI (14)
47.22
Neutral
STOCH (9,6)
56.24
Neutral
STOCHRSI (14)
49.69
Neutral
MACD (12,26)
-1.00
Sell
ADX (14)
18.50
Buy
Williams %R
-53.17
Buy
CCI (14)
6.48
Neutral
ATR (14)
2.54
-
Ultimate Oscillator
48.60
Neutral
ROC
-0.27
Sell
Neurogene’s (NGNE) Relative Strength Index (RSI) is 47.22, creating a Neutral signal.
Neurogene’s (NGNE) Trend Strength Indicator (ADX) is 18.50, creating a Buy signal.
Neurogene’s (NGNE) Commodity Channel Index (CCI) is 6.48, creating a Neutral signal.
Neurogene’s (NGNE) Price Rate of Change (ROC) is -0.27, creating a Sell signal.

FAQ

Is NGNE a Buy, Hold, or Sell?
Based on NGNE’s technical indicators, NGNE is a Buy.
    What is NGNE’s RSI (14)?
    NGNE’s RSI (14) is 47.22, which suggests NGNE is a Neutral.
      What is NGNE’s MACD?
      NGNE’s MACD is -1.00, which suggests NGNE is a Sell.
        What is NGNE’s 5-day moving average?
        NGNE’s 5-day moving average is 32.56, which suggests NGNE is a Buy.
          What is NGNE’s 20-day moving average?
          NGNE 20-day moving average is 32.68, which suggests NGNE is a Buy.
            What is NGNE’s 50-day moving average?
            NGNE’s 50-day moving average is 37.68, which suggests NGNE is a Sell.
              What is NGNE’s 200-day moving average?
              NGNE’s 200-day moving average is 23.88, which suggests NGNE is a Buy.
                What is NGNE’s Williams % R (14)?
                NGNE’s Williams % R (14) is -53.17, which suggests NGNE is a Buy.
                  What is NGNE’s CCI (14)?
                  NGNE’s CCI (14) is 6.48, which suggests NGNE is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis